Made In USAFor Laboratory Research OnlyCOAs Not Yet AvailableExplore Compound Research ProfilesCompare Catalog SizesResearch Requests Reviewed IndividuallyNot For Human Or Veterinary Use
WYZ LABS
0Account
Research blend

Metabolic blend

Catalog size
Price pending
USD per vial · Size pendingCatalog price
Research only

The Metabolic Blend lists NAD+, MOTS-c and 5-amino-1MQ, connecting three distinct research topics in cellular energetics and nicotinamide metabolism.

Explore the research profile

Submit an unpaid laboratory order request for manual review. Availability and any pending amounts require confirmation.

No reservation or purchase is made by adding a material.
View documentation status ← Back to collection
Listed components
NAD+ 100 mg + MOTS-C 10 mg + 5-Amino-1MQ (amount pending)
Format
Awaiting confirmation
Availability
Confirmed during review

Catalog quantities are not assay results.

In the literature

The components. The research context.

Coenzyme, mitochondrial peptide and NNMT-inhibitor research blend

Understanding the formulation

This catalog grouping contains three chemically different materials: NAD+ is a nucleotide coenzyme, MOTS-c is a mitochondrial-derived peptide and 5-amino-1MQ is a synthetic quinolinium small molecule. It should not be described as a single peptide. The listing specifies NAD+ and MOTS-c quantities, while the 5-amino-1MQ quantity and total formulation size remain pending.

Reference identity
Research class
Coenzyme, mitochondrial peptide and NNMT-inhibitor research blend
Catalog search names
NAD+ MOTS-C 5-Amino-1MQ blend

This reference describes the published literature. Exact supplied form and chemical specifications require product-specific documentation. The studies are linked in Selected literature.

Why these components are studied

NAD+ participates in redox reactions and enzyme-linked signaling. MOTS-c experiments explore metabolic stress responses, including AMPK-associated pathways. 5-amino-1MQ inhibits NNMT, an enzyme that methylates nicotinamide. These topics intersect biochemically, but supplying extracellular NAD+ is not the same experiment as changing intracellular nicotinamide metabolism or mitochondrial-peptide signaling.

Component and related research

These links provide research context; they do not confirm the exact materials in this formulation.

Documented lines of inquiry

Research areas

  1. 01

    Direct NAD+ disposition

    A small human pilot measured circulating and urinary metabolites during direct NAD+ administration. It addressed metabolism and excretion, not efficacy of a three-component blend or broad longevity claims. [1]

  2. 02

    Mitochondrial-derived signaling

    Foundational MOTS-c work connected peptide signaling with metabolic changes in cells and mice. It does not establish human benefits from an administered MOTS-c product. [2]

  3. 03

    NNMT inhibition in models

    5-amino-1MQ experiments included adipocytes and diet-induced obesity in mice. Their findings concern the specific inhibitor and model, not an independently assembled NAD+/MOTS-c combination. [3]

Study topics describe the cited models, not established benefits of this catalog material.

Reading the evidence

What the studies
can tell us.

Component evidence · finished blend untested in cited studies

The components have different levels and types of evidence: preliminary direct-NAD+ human pharmacology and predominantly preclinical intervention evidence for MOTS-c and 5-amino-1MQ. None of the selected studies evaluates the finished Metabolic Blend or demonstrates a coordinated three-part effect.

What remains uncertain

The unconfirmed 5-amino-1MQ quantity prevents an exact formulation comparison. Extracellular breakdown, intracellular compartmentalization and chemical compatibility also limit predictions from ingredient lists. Neither NAD-precursor trials nor studies of other NNMT inhibitors validate this mixture, its stability or any WYZ batch.

Read the source

Selected literature

These papers concern individual components or related molecules. They do not validate this finished blend.

  1. 01PubMed
  2. 02
    2015 · Cell and animal study

    The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance (opens a new tab)

    Foundational sequence, metabolic-pathway and mouse experiments.

    PubMed
  3. 03PubMed

Literature reviewed October 2026. This is a selected research overview, not an exhaustive systematic review. Published findings do not establish the identity, purity, sterility or suitability of any WYZ batch. For laboratory research only; not for human or veterinary use.

Before you begin

The details behind
the material.

Specifications and storage

Final product specifications and product-specific storage instructions have not been supplied. Review the original documentation and your laboratory’s procedures before obtaining or using the material.

Research use only

For qualified laboratory researchers. Not for human or veterinary use. Product information is not medical advice or a recommendation for personal use.

What to look for in a COA

Continue exploring.

All materials

Other research blends in the collection.

Research Blends

Wolverine

Wolverine pairs BPC-157 with a TB-500-listed component, connecting preclinical tendon and gastrointestinal research with thymosin-related identity questions. The exact TB-500 sequence still requires confirmation.

$65USD / vial · 10 mg
Research only
View details
Before you explore

Laboratory
research only.

Please confirm the following to enter the Wyz Labs collection.

Select both confirmations to continue.

Your acknowledgment is remembered for this browser session. This is a self-declaration, not identity verification.